The Scientific Advisory Board is a focused group of external thought leaders that provide independent opinions and recommendations about Caris Life Sciences® initiatives and services. The Caris advisory board includes experts in contemporary cancer research, drug and diagnostic development, clinical trial design, regulatory issues and reimbursement policy, as well as clinical oncologists from both the community and academic medical center settings.

Vice Chairman

Chairman, Caris Scientific Advisory Board

Vice Chairman

Chairman of the Genomics England Access Committee

Former Vice President and Head of Precision Medicine at Bristol-Myers Squibb

Co-Director, Complex Adaptive Systems Initiative, Arizona State University

Director, National Biomarker Development Alliance, Arizona State University

Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center

Adjunct Professor, Department of Statistics, Rice University

Professor of Medicine, Harvard Medical School

Associate Director for Clinical Science, Dana-Farber/Harvard Cancer Center

Professor, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center

Deputy Director, University of Cincinnati Cancer Institute and The Barrett Cancer Center

Paul & Carolyn Flory Endowed Professor, Obstetrics & Gynecology, University of Cincinnati

Professor of Microbiology and Immunology, Stanford University

Vice President and Executive Dean for West Virginia University Health Sciences

Professor of Internal Medicine, Pulmonary and Critical Care Medicine, West Virginia University

Chief, Division Hematology and Oncology, Department of Medicine, Georgetown University

Professor of Medicine and Oncology, Georgetown University

Leader, National RAS Initiative

David A. Wood Distinguished Professor of Tumor Biology and Cancer Research, University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

Neurologist and Management Consultant, Johns Hopkins School of Medicine

President and Chief Executive Officer, ESSA Pharma, Inc.

Former SVP, Oncology Research and Development, Biogen Idec

Professor, Computational Biology and Bioinformatics, Harvard School of Public Health

Professor, Cancer Biology, Dana-Farber Cancer Institute

Chair of the Robert J. Tomsich Pathology & Laboratory Medicine Institute (RT-PLMI), Cleveland Clinic

Executive Director, West Cancer Center

Division Chief, Hematology Oncology, The University of Tennessee Health Science Center

Chief Data Scientist and Head of Computational Biology, Vir Biotechnology Inc.

Professor, Lewis Sigler Institute for Integrative Genomics, Princeton University

Deputy Director for Genomics, Simons Center for Data Analysis at the Simons Foundation

CEO and Managing Partner, New York Cancer & Blood Specialists

Clinical Assistant Professor of Medicine, University Hospital at Stony Brook

Vice Chair, SWOG GU Committee

Medical Director, Genitourinary Research Program, US Oncology Research, Comprehensive Cancer Centers of Nevada